Description
An allosteric modulator of the CB1 receptor; the S-(–) enantiomer of GAT211; enhances the binding of CP 55,940 to CHO cells expressing hCB1 by 130% at 1 μM; enhances the activity of 2-AG, AEA, and CP 55,940 in arrestin2, as well as ERK1/2 and PLCβ3 phosphorylation, assays to HEK293 cells expressing hCB1; enhances depolarization-induced suppression of excitation but does not inhibit excitatory postsynaptic currents in murine autaptic hippocampal neurons at 1 μM; reduces intraocular pressure by 5.8 and 7.7 mm Hg after 6 and 12 hours, respectively, in a nee transgenic mouse model of ocular hypertension at 0.2%, topical
Formal name: 3-[(1S)-2-nitro-1-phenylethyl]-2-phenyl-1H-indole
Synonyms:
Molecular weight: 342.4
CAS: 889860-85-9
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology|Allosteric Modulators||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids||Research Area|Neuroscience|Ophthalmology